The contribution of biophysical and structural studies of protein self-assembly to the design of therapeutic strategies for amyloid diseases.

Structural basis of membrane disruption and cellular toxicity by Îą-synuclein oligomers.

Inhibiting the Ca(2+) Influx Induced by Human CSF.

Absolute Quantification of Amyloid Propagons by Digital Microfluidics.

Thermodynamics of Polypeptide Supramolecular Assembly in the Short-Chain Limit.

Delivery of Native Proteins into C. elegans Using a Transduction Protocol Based on Lipid Vesicles.

Clusterin protects neurons against intracellular proteotoxicity.

Application of Lysine-specific Labeling to Detect Transient Interactions Present During Human Lysozyme Amyloid Fibril Formation.

The relevance of contact-independent cell-to-cell transfer of TDP-43 and SOD1 in amyotrophic lateral sclerosis.

Sequential Release of Proteins from Structured Multishell Microcapsules.

Scaling behaviour and rate-determining steps in filamentous self-assembly.

Gradient-free determination of isoelectric points of proteins on chip.

Monomeric and fibrillar ι-synuclein exert opposite effects on the catalytic cycle that promotes the proliferation of Aβ42 aggregates.

Silk micrococoons for protein stabilisation and molecular encapsulation.

Protein homeostasis of a metastable subproteome associated with Alzheimer's disease.